TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 101,205 | 70,375 | 55,560 |
Financial expenses | 1 | 4 | 11 |
Earnings before taxes | 14,637 | 10,247 | 4,112 |
EBITDA | 13,622 | 6,870 | 3,449 |
Total assets | 45,902 | 29,893 | 19,722 |
Current assets | 41,128 | 25,084 | 15,441 |
Current liabilities | 15,723 | 8,984 | 5,871 |
Equity capital | 28,612 | 19,562 | 12,922 |
- share capital | 101 | 100 | 100 |
Employees (average) | 13 | 12 | 12 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 62.3% | 65.4% | 65.5% |
Turnover per employee | 7,785 | 5,865 | 4,630 |
Profit as a percentage of turnover | 14.5% | 14.6% | 7.4% |
Return on assets (ROA) | 31.9% | 34.3% | 20.9% |
Current ratio | 261.6% | 279.2% | 263.0% |
Return on equity (ROE) | 51.2% | 52.4% | 31.8% |
Change turnover | 30,830 | 14,815 | 4,104 |
Change turnover % | 44% | 27% | 8% |
Chg. No. of employees | 1 | 0 | 2 |
Chg. No. of employees % | 8% | 0% | 20% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.